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Abstract The FER locus in the mouse encodes two tyrosine
kinases, p94fer and p51ferT. While p94fer accumulates in the
cytoplasm and nucleus of most mammalian cells the expression of
p51ferT is restricted to the nucleus of meiotic primary
spermatocytes. The cellular function of the FER kinases is not
understood, nor has a substrate for these enzymes been
characterized. To identify putative substrates of p94fer and
p51ferT, the two enzymes were used as ‘baits’ in the yeast two-
hybrid screening system. cDNAs encoding the mouse TATA
element modulatory factor (TMF) were repeatedly isolated in
this assay. TMF was previously shown to bind the TATA element
in RNA polymerase II promoters and impaired their functioning
in a cell free transcription system. Both p94fer and p51ferT
phosphorylated the TMF protein in in vitro and in vivo kinase
assays. Sequential deletions showed that the carboxy-terminal
region of TMF was essential for phosphorylation. In situ
hybridization analysis revealed the preferential accumulation of
TMF transcripts in meiotic spermatogenic and oogenic cells.
p94fer and p51ferT may thus modulate the suppressive activity of
TMF during cellular growth and in defined differentiation
processes.
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1. Introduction
In mammalian cells signal transduction pathways induced
by growth factors are usually initiated by tyrosine phosphor-
ylation events which occur on membranal receptors [36] or on
the tyrosine kinases associated with them [26]. As the signal-
ing cascade propagates toward the cell nucleus these phos-
phorylation events lead to serine and threonine phosphoryla-
tion activities [9,22]. In the nucleus, tyrosine phosphorylation
events are relatively rare, yet several nuclear tyrosine kinases
have been identi¢ed and characterized. These can be divided
into two main groups of src-related and non-related nuclear
tyrosine kinases [30,35]. The role of most of these tyrosine
kinases is however not well understood.
p94fer is an evolutionarily conserved tyrosine kinase [29]
encoded by the FER locus in mouse [11], rat [27] and human
[19]. p94fer accumulates in both cytoplasm and nucleus of cells
[18]. Its nuclear accumulation becomes most prominent, how-
ever, concomitantly with the progression of cells toward the
G1/S transition state (Ben-Dor and Nir, submitted). The pres-
ence of p94fer has been documented in most mammalian cell
lines analyzed [10,15,19,27]. It could not be detected, however,
in pre-B, pre-T and T cells [15].
A truncated form of p94fer, termed p51ferT, is encoded by a
testis-speci¢c FER transcript [11,24]. This kinase accumulates
in the nucleus of meiotic primary spermatocytes [11,20].
p51ferT and p94fer di¡er in their N-termini but they do share
common SH2 and kinase domains [11,19]. The FER kinase
domain [19,27] is 70% and 50% homologous to the kinase
domains of two other known nuclear and cytoplasmic tyro-
sine kinases, c-Fes [14,31,38,39] and c-Abl [34], respectively.
These four kinases encompass a group of the known SH2-
containing mammalian nuclear tyrosine kinases, which are
not src-related [34,38,39]. While the cellular role of the nuclear
c-Fes is not known, the cytoplasmic fraction of that enzyme
was shown to promote proliferation of vascular endothelial
cells [13] and has been implicated in the signal transduction
elicited by cytokines in hematopoietic cells [17,21]. The nu-
clear function of c-Abl has been linked to cellular response to
genotoxic stress [40,41], and has been implicated in potentiat-
ing the activity of RNA polymerase II in S phase [37].
The cytoplasmic fraction of p94fer interacts with the cate-
nin-like substrate pp120 in ¢broblastic cells [25] and its nu-
clear fraction was found to associate with the cell chromatin
[18]. The kinase activity of p94fer is elevated in growth factor-
stimulated ¢broblastic cell lines [25]. However, no direct link
of p94fer to regulation of cell growth has been shown, nor has
a substrate for p94fer or p51ferT been characterized, thus leav-
ing the cellular role of p94fer and p51ferT elusive.
Ectopic expression of p94fer and p51ferT led to tyrosine
phosphorylation of 66 kDa and 120 kDa proteins in CHO
cells [6]. These proteins may mediate the cellular functions
of the FER tyrosine kinases [6].
In order to further the understanding of the cellular func-
tions of the FER proteins, the yeast two-hybrid system has
been applied for identi¢cation of putative substrates of these
enzymes. By using that approach and complementary phos-
phorylation assays, the TATA element modulatory factor
(TMF) was found to serve as a phosphorylation target for
both p94fer and p51ferT.
2. Materials and methods
2.1. Point mutagenesis of the FER proteins
Mutations were introduced in the FER proteins using the oligonu-
cleotide-directed mutagenesis without phenotypic selection procedure
[2], with modi¢cations as follows.
Mutagenized fragments were cloned in pBluescript (KS) and the
R408 M13 strain (Promega) was used as a helper phage for prepara-
tion of single strand DNA stocks.
Gly-571 was changed to arginine in p94fer, by using the oligonucleo-
tide -gaattactgCgcaaggga- in which the marked cytosine replaced the
original guanine in the fer cDNA, thus creating a new arginine encod-
ing triplet -cgc [11]. The modi¢ed oligonucleotide was extended with
T7 DNA polymerase and HB101 cells were then transformed with the
double strand DNA.
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2.2. Construction of plasmids
2.2.1. Two-hybrid plasmids. Native and mutated fer or ferT
cDNAs were £anked by BamHI linkers and were then inserted in
the BamHI site of the pBTM116 vector [3]. In these plasmids, which
served as ‘bait’ expression vectors in the two-hybrid screen, the FER
proteins were produced as LexA fusion proteins.
The mouse testes cDNA library, screened in this work, was cloned
in the pGAD10 plasmid from which the cDNAs were expressed as
GAL4 activating domain fusion proteins (Clontech).
2.2.2. Maltose binding protein (MBP) expression plasmids. Fer
and ferT cDNAs £anked by BamHI linkers were inserted into a
BamHI site located at the 3P end of the malE gene, in the pMAL-c2
vector. Inserting the FER cDNAs in the same translation frame as
malE allowed the production of MBP-FER fusion proteins from the
pMAL-c2 vector (New England BioLabs Inc.)
2.2.3. Glutathione S-transferase (GST) expression plasmids.
D1TMF encoding a mouse TMF fragment that extends from Asp-
381 to Ile-1089 (Fig. 2A) was cut out of the pGAD10 expression
vector with BamHI and EcoRV. This fragment was then inserted
into a BamHI-EcoRI cut pGEX2 plasmid [33] in which the EcoRI
end was ¢lled in with the Klenow DNA polymerase fragment.
D2TMF which encodes Asp-381 to Asp-864 in the mouse TMF
(Fig. 2A) was obtained by cutting the D1TMF fragment with
Asp718 and ¢lling in with Klenow fragment. This fragment was
then inserted into a linear pGEX2 plasmid which harbored a cohesive
BamHI site and a ¢lled in EcoRI site, at its ends.
The D3TMF fragment encoding Lys-637 to Ile-1089 in the mouse
TMF was obtained by cutting the D1TMF fragment with BglII and
SphI. The SphI end was turned blunt with T4 DNA polymerase and
the obtained fragment was inserted into a pGEX2 vector harboring
BamHI and ¢lled in EcoRI site at its ends.
2.2.4. pcDNA3 expression plasmids. The TMF cDNA fused to an
in£uenza virus hemagglutinin epitope (HA) at its 5P end (HA-TMF)
was inserted between the BamHI and NotI sites in the pcDNA3 ex-
pression vector (Invitrogen). In that vector, which carries the SV40
origin of replication, the TMF cDNA is transcribed under the control
of the human cytomegalovirus promoter. This plasmid was termed
pcDNA3TMF.
2.2.5. pECE expression plasmids. The native and mutated p94fer
cDNAs were inserted between the HindIII and EcoRI sites in the
pECE expression vector, [8]. In that vector, which also carries the
SV40 origin of replication, the p94fer cDNA is transcribed under the
control of the SV40 early promoter [8]. The plasmid that carries the
native p94fer cDNA was termed pECEfer and the one carrying the
mutated fer cDNA (Gly-571 to Arg) was termed pECEfer571.
2.3. Yeast two-hybrid screening
p94fer and p51ferT pBTM116 expression plasmids were introduced
into CTY10-5d yeast strain which harbors two LexA operators in a
UAS-less promoter upstream of a lacZ reporter gene [3,4]. Western
analysis using K-FER antibodies [20] con¢rmed high levels of expres-
sion of the LexA-FER fusion proteins (data not shown). 0.5U106
cDNA clones from a mouse testes library (Clontech), fused to the
GAL4 activating domain in the pGAD10 vector [3,4], were then
transfected to CTY10-5d yeast cells that expressed a LexA-FER fu-
sion protein. Seven positive clones drove LexA-FER-dependent ex-
pression of the lacZ gene. These were isolated and further character-
ized. Inserts were cut out of the pBTM116 vector with SalI and were
recloned into the SalI site of the pBluescript plasmid. DNA sequenc-
ing of the cloned inserts was performed by the Biological Services of
the Weizmann Institute of Science using an Applied BioSystem 373
DNA Sequencer and dideoxy Taq terminators. The obtained sequen-
ces were compared against the GenBank/EMBL sequences databases.
2.4. Production of MBP fusion proteins in Escherichia coli cells
E. coli BL21 cells transformed with MBP expression plasmids were
exposed to 0.1 mM IPTG for 20 min and were then sonicated in MBP
bu¡er (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 4 mM EDTA and 10
mM L-mercaptoethanol) to which protease inhibitor mixture (20 mg/
ml Pefabloc, 10 Wg/ml aprotinin, 10 Wg/ml leupeptin and 20 Wg/ml
benzamidine) was added.
The protein extracts were cleared by centrifugation for 30 min at
13000Ug. Supernatants were loaded on an amylose column [5] that
was then washed with MBP bu¡er. MBP fusion proteins were eluted
and stored in MBP bu¡er containing 1 mM EDTA, 10 mM maltose
and 10% glycerol at 4‡C.
2.5. Production of GST fusion proteins in E. coli cells
E. coli BL21 cells transformed with GST expression plasmid were
treated with 0.1 mM IPTG for 20 min and sonicated in GST bu¡er
(Tris-HCl pH 7.5, 4 mM EDTA, 100 mM NaCl, 10 mM L-mercap-
toethanol) and mixture of protease inhibitors. Cleared lysates were
loaded on glutathione agarose beads [33] which were then washed
with cold GST bu¡er containing 1% Triton X-100 and then with
cold GST bu¡er alone. GST fusion proteins were stored on the glu-
tathione beads in GST bu¡er containing 1 mM EDTA, at 4‡C.
2.6. In vitro kinase assay
30 Wl glutathione agarose beads carrying 1 Wg substrate fused to
GST were added to 1 Wg MBP-FER fusion protein, in 60 Wl kinase
reaction containing HNTG bu¡er (20 mM HEPES pH 7.5, 150 mM
NaCl, 10% glycerol, 10 mM MgCl2, 10 mM MnCl2) and 6 Wl
[Q-32P]ATP (3000 ci/mmol). The reaction was incubated for 15 min
at room temperature. Glutathione agarose beads carrying the phos-
phorylated substrates were then washed with 150 mM NaCl, 50 mM
Tris pH 7.5, 10 mM EDTA and 1% Triton. Washed beads were
resuspended in Laemmli bu¡er, heated for 3 min at 95‡C and loaded
onto a SDS 8^16% polyacrylamide gradient gel. Proteins were electro-
blotted onto an Immobilon-P membrane (Millipore), which was dried
and exposed to Fuji X-ray ¢lm.
2.7. Phosphoamino analysis
A PVDF piece carrying a phosphorylated protein was incubated in
300 Wl 6 M HCl for 60 min at 110‡C. The supernatant was transferred
to an Eppendorf tube, dried and hydrolysis products were redissolved
in 20 ml H2O. 5 Wl were loaded on a TLC plate together with 0.5 Wg
phosphotyrosine, phosphoserine and phosphothreonine standards.
First-dimension electrophoresis was carried out for 20 min in 1500
V, with pH 1.9 bu¡er: 0.58 M formic acid and 1.36 M glacial acetic
acid. The second dimension was run for 30 min in 1300 V with pH 3.5
bu¡er: 0.5 mM EDTA, 0.5% (v/v) pyridine and 0.87 mM glacial
acetic acid. The TLC plate was dried for 20 min at 50‡C, stained
with ninhydrin dye and exposed to Kodak XAR-5 ¢lm.
2.8. In vivo kinase assays
The in vivo kinase assay was carried out in transiently transfected
COS1 cells. 1.2U106 cells were cotransfected with 4.5 Wg pECEfer or
pECEfer571 and 1.5 Wg pcDNA3TMF, in the presence of 36 Wl lipo-
fectamine (Gibco-BRL). Cells were lysed 40 h later, using lysis bu¡er
containing 3 mM sodium orthovanadate [6]. HA-TMF was immuno-
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Fig. 1. Structure of TMF. Empty box represents the protein N-terminal portion. Light gray denotes the DNA binding domain (DBD) which
contains at its N-terminal portion leucine zippers that can potentially form coiled coil (CC) structures. Dark gray de¢nes the TMF carboxy-ter-
minal tail which includes a potential coiled coil region at its end (cc). The region in TMF which harbors the p51ferT/p94fer571 (see text) binding
sequences and potential tyrosine phosphorylation site in TMF is also shown.
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precipitated with anti-hemagglutinin antibodies (Boehringer Mann-
heim), Western blotted [6] and reacted with monoclonal anti-phospho-
tyrosine antibodies (pT66, Sigma Immunochemicals).
2.9. Northern blot analysis
Whole cell RNA was extracted using the LiCl/urea precipitation
methods, as described ([1], procedure C). RNA was resolved in a
1.2% formaldehyde agarose gel and transferred to a Magna nylon
membrane. The ¢lter was hybridized with a randomly primed mouse
TMF cDNA (encoding the D1TMF fragment, Fig. 2A) according to
standard procedures [32] and washed in 0.1USSC and 0.1% SDS at
60‡C. The ¢lter was exposed to Kodak XAR-5 ¢lm with intensifying
screen.
2.10. In situ hybridization
8^10 Wm cryosections were hybridized essentially as described be-
fore [28]. The sections were mounted on SuperFrost/Plus slides (Men-
zel Glaser), and re¢xed with 4% paraformaldehyde. Following prehy-
bridization, the slides were hybridized at 50‡C with antisense or sense
TMF RNAs. A 1659 bp long TMF fragment encoding the last 553 aa
of this protein was used as a probe. Posthybridization washes included
treatment with RNase A (50 Wg/ml), and stringent washes with
0.1USSC at 60‡C. The slides were dipped into NTB-2 emulsion (Ko-
dak), exposed for 4^7 days (gonads and embryos, respectively), devel-
oped, and stained with toluidine blue.
3. Results
3.1. TATA element modulatory factor (TMF) is a putative
substrate of the FER tyrosine kinases
To isolate cDNAs encoding potential substrates of p94fer
and p51ferT, the yeast two-hybrid system has been applied
[3,4]. Usage of an enzyme as a ‘bait’ for detection of en-
zyme-substrate interactions in that assay may necessitate for-
mation of relatively stable enzyme-substrate complexes. In
order to impair the turnover of the FER protein enzymatic
activity, mutations were introduced in the ATP binding site of
these kinases [7]. These mutations should favor the formation
of stable complexes of p94fer or p51ferT with their putative
substrates [16]. The native and mutated FER cDNAs were
cloned in the yeast pBTM116 expression vector, and the
FER kinases were expressed as LexA fused ‘baits’ in the yeast
CTY10-5d cells [3,4]. Of the expressed constructs, the native
enzymes and the Gly571-p94fer mutant, in which the ¢rst gly-
cine of the GxGxxG ATP consensus binding site [7,11] is
mutated to arginine, were most e⁄ciently produced in the
transformed yeast cells (data not shown). These proteins
were further used as ‘baits’ in the two hybrid screen.
0.5U106 cDNA clones from a mouse testes library, fused to
the GAL4 activating domain in the pGAD10 vector, were
then transfected to CTY10-5d yeast cells that expressed each
one of the LexA-FER enzymes. Seven clones encoding pro-
teins that interact with the FER kinases were isolated and
further characterized. Sequencing of these clones revealed
that one clone was independently isolated with both native
p51ferT and Gly571-p94fer expressing cells. That clone encodes
the TMF [12]. TMF is a 123 kDa protein ([12] and Fig. 1)
that binds to the TATA element of some RNA polymerase II
promoters and represses their activity by competing with the
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Fig. 2. In vitro phosphorylation of TMF by the FER tyrosine kin-
ases. A: Murine TMF fragments exposed to in vitro phosphoryla-
tion assays. Empty box represents the protein N-terminal portion,
stippled represents the TMF DNA binding region and black denotes
the TMF carboxy-terminal domain. The numbers given in the TMF
scheme correspond to the aa numbers in the human TMF [12]. B:
MBP-p94fer (lane 1), MBP-p94fer with GST-D3TMF (lane 2), p94fer
with GST (lane 3), MBP-p51ferT (lane 4), MBP-p51ferT with GST-
D3TMF (lane 5), MBP- MBP-p51ferT with GST (lane 6) and GST-
D3TMF alone (lane 7) were incubated in in vitro kinase assays. The
enzymes were washed away from the glutathione agarose beads at
the end of the reactions presented in lanes 2, 3, 5 and 6. Phosphory-
lated proteins were resolved in PAGE and transferred to PVDF
membrane which was exposed to Kodak XAR-5 ¢lm. Arrows on
the left indicate migration distances of enzymes and substrates. Mi-
gration distances of known molecular weight markers are shown on
the right. C: Phosphoamino analysis of in vitro phosphorylation
products. Products from lane 5 in B were exposed to phosphoamino
analysis. Locations of unlabeled, known phosphorylated amino
acids are shown, phosphoserine (lane 1), phosphotyrosine (lane 3),
phosphothreonine (lane 4). Degradation products of in vitro phos-
phorylated protein were loaded in lane 2. Arrow indicates labeled
phosphotyrosine.
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binding of TATA binding protein (TBP), to the TATA ele-
ment of these promoters [12]. TMF binds most e⁄ciently to
nucleotides 346 to 310 of the HIV TATA element [12]. De-
letion mapping analysis revealed that Gly571-p94fer and the
native p51ferT bind to sequences within a 542 amino acids
long region in the murine TMF (Fig. 1). This fragment, which
extends from Asp-540 to Ile-1089 in the mouse TMF, contains
the DNA binding and carboxy-terminal domains of that fac-
tor (Fig. 1). Wild type p94fer did not bind to TMF in that
two-hybrid assay (data not shown). This may re£ect the tran-
sient interaction between p94fer and TMF which most prob-
ably results from the autophosphorylation and self-activation
of p94fer but not p51ferT in the expressing yeast cells (data not
shown).
To test whether TMF can serve as a substrate for the p94fer
and p51ferT kinases, a TMF fragment extending from Lys-637
to Ile-1089 (D3TMF in Fig. 2A) was produced as a GST
fusion protein [33] in bacterial cells. The GST-D3TMF fusion
protein (Fig. 2A) was incubated in the presence of bacterially
produced MBP-p94fer and MBP-p51ferT fusion proteins [5], in
an in vitro kinase assay [19]. Bacterially produced MBP-
p51ferT and MBP-p94fer fusion proteins retained their enzy-
matic activities and exerted tyrosine autophosphorylation ac-
tivity in that assay (Fig. 2B, lanes 1 and 4, respectively). MBP-
p94fer and p51ferT also phosphorylated the GST-D3TMF fu-
sion protein (Fig. 2B, lanes 2 and 5, respectively) but they did
not phosphorylate the GST protein itself (Fig. 2B, lanes 3 and
6). As expected, the GST-D3TMF fusion protein did not ex-
hibit any autophosphorylation activity (Fig. 2B, lane 7), thus
attributing its phosphorylation in the in vitro kinase reaction
to the kinase activities of p94fer and p51ferT.
Phosphoamino analysis con¢rmed that the phosphorylation
activity exerted by the FER kinases in these in vitro assays led
to the accumulation of tyrosine rather than serine or threo-
nine phosphorylation products (Fig. 2C).
To test the tyrosine phosphorylation of TMF by p94fer in
vivo, a transient cotransfection expression kinase assay was
established. An intact TMF cDNA linked to an in£uenza
virus HA epitope at its 5P end (HA-TMF) was inserted into
the pcDNA3 expression vector. This vector (pcDNA3TMF)
was cotransfected into COS1 cells together with a pECE vec-
tor which carries the native (pECEfer) or mutated
(pECEfer571) p94fer cDNA.
Ectopically expressed TMF was immunoprecipitated from
COS1 extracts 40 h after transfection, Western blotted and
reacted with anti-phosphotyrosine monoclonal antibodies. Ec-
topic coexpression of native TMF and p94fer led to tyrosine
phosphorylation of TMF (Fig. 3). However, TMF was not
phosphorylated when coexpressed with an inactive p94fer
(pECEfer517) (Fig. 3), thus linking the tyrosine phosphoryla-
tion of TMF in that assay to the exogenous p94fer kinase
activity.
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Fig. 4. In vitro phosphorylation of the carboxy-terminal domain of
TMF. MBP-p94fer with GST-D1TMF (see Fig. 2A) (lane 1), MBP-
p94fer with GST-D2TMF (see Fig. 2A) (lane 2), MBP-p51ferT with
GST-D1TMF (lane 3) and MBP-p51ferT with GST-D2TMF (lane 4)
were incubated in in vitro kinase assays. Phosphorylation products
were resolved in PAGE, electroblotted onto PVDF membrane that
was exposed to Kodak XAR-5 ¢lm. Arrows on the left indicate mi-
gration distances of putative substrates. Migration distances of
known molecular weight markers are shown on the right side.
Fig. 5. Northern blot analysis of TMF expression. Whole cell RNA
was extracted from 10.5 day post coitus (dpc) mouse embryos, 14.5
dpc, 17.5 dpc mouse placenta, brain of 45 day old mice, gut, spleen,
kidney, testis and ovary. Samples were fractionated in a 1.2% form-
aldehyde agarose gel, transferred to Magna nylon membrane (MSI)
which was then hybridized with a mouse TMF probe and was ex-
posed to Kodak XAR-5 ¢lm. Arrows on the left indicate migration
distances of the TMF transcripts. Longer exposure revealed the
presence of the 4 and 4.5 kb transcripts in all tissues analyzed (data
not shown).
Fig. 3. In vivo phosphorylation of TMF by p94fer. Hemagglutinin-
tagged TMF (HA-TMF) was transiently coexpressed in COS1 cells
together with native (wt) or Gly-571 mutated p94fer (mut). HA-
TMF was immunoprecipitated with anti-hemagglutinin antibodies,
Western blotted and reacted with anti-phosphotyrosine (upper pan-
el) or anti-hemagglutinin antibodies (middle panel). p94fer was de-
tected with anti-FER antibodies (lower panel).
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3.2. The C-terminal region of TMF is essential for
phosphorylation by the FER proteins
The FER tyrosine kinases bind to a 542 aa long fragment in
TMF that contains the DNA binding domain and the car-
boxy-terminal tail of that protein (Fig. 1). This suggests the
phosphorylation of one of these subregions by the FER ty-
rosine kinases. In order to ¢nd which part of TMF is phos-
phorylated by the FER enzymes, two TMF subfragments
were exposed to the phosphorylation activity of these en-
zymes. One fragment contained the DNA binding and car-
boxy-terminal domains of TMF (D1TMF, Fig. 2A), while
the other included only the DNA binding domain (D2TMF,
Fig. 2A). These TMF segments were produced in E. coli as
GST fusion proteins and equal amounts of them were incu-
bated with MBP-p94fer, in an in vitro kinase assay. Incubation
of the GST-TMF-DNA binding domain (D2TMF, Fig. 2A)
with MBP-p94fer fusion protein did not lead to phosphoryla-
tion of this TMF subfragment (Fig. 4, lanes 2 and 4). The
same result was obtained when the N-terminal portion of
TMF (Fig. 1) was attached to the DNA binding domain
(data not shown). Linking the TMF carboxy-terminal tail to
the DNA binding domain of that factor (D1TMF, Fig. 2A)
restored the phosphorylation of TMF by p94fer and p51ferT
(Fig. 4B, lanes 1 and 3, respectively). The C-terminal region of
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Fig. 6. TMF localization in the adult gonads. Bright (A) and dark (B) ¢eld view of a section of 17 day postnatal testis hybridized to TMF
antisense probe. About half of the tubules express high levels of TMF, while the others express much lower levels. Bright (C) and dark (D)
¢eld view of adult testis (te) and epididymis (ep). All seminiferous tubules express very high levels of TMF, while no signi¢cant signal was ob-
served in the spermatozoa stored in the epididymis. Bright (E) and dark (F) ¢eld enlargements of the adult testis. Hybridization signal is seen
over the developing spermatocytes, but not over elongated spermatids (arrow), or interstitial Leydig cells (Le). Bright (G) and dark (H) ¢eld
view of adult ovary. TMF RNA is localized in growing oocytes (marked by arrows). Bar = 100 Wm (A, B, G and H), 250 Wm (C and D), 50
Wm (E and F).
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TMF is thus essential for the phosphorylation of that protein
by p94fer.
3.3. Preferential expression of TMF in germ cells
The data presented above suggested a functional link be-
tween the FER proteins and TMF. Since the expression of
p51ferT is restricted to spermatogenic cells [11,20] and p94fer is
expressed in most mammalian cells [10,15,19,27] we turned to
check whether TMF patterns of expression overlap with those
of the FER RNAs. RNAs were extracted from various mouse
tissues and analyzed by Northern blot hybridization using a
TMF labeled probe. Two discrete TMF transcripts of 4.5 and
4 kb [12] were detected in all tissues analyzed (Fig. 5). These
transcripts accumulated, however, to remarkably high levels
in mouse testis (Fig. 5). The identity of the cells expressing
TMF within the gonads was assessed by in situ RNA hybrid-
ization. Sections of developing prepuberal testis and of adult
testis were examined. At 7 and 12 days postnatally, germ cells
expressed moderate levels of TMF (not shown). By 17 days,
about half of the tubules expressed high levels in the germ cell
compartment, while the other half retained the moderate lev-
els observed in earlier stages (Fig. 6A,B). 22-day (not shown)
and adult testes (Fig. 6C,D) exhibited high levels in all tu-
bules. Higher magni¢cation indicated that germ cells from
around mid-pachytene to round spermatid stage [23] ex-
pressed high levels of TMF (Fig. 6E,F, and not shown). Elon-
gated spermatids (Fig. 6E,F) and spermatozoa stored in the
epididymis (Fig. 6C,D) expressed only low levels. No expres-
sion could be seen in Sertoli or interstitial Leydig cells (Fig.
6E,F). Analogously, in the adult ovary, growing secondary
oocytes expressed much higher levels than the surrounding
granulosa or interstitial cells (Fig. 6G,H).
4. Discussion
p94fer and p51ferT belong to a group of nuclear tyrosine
kinases whose cellular functions are not well understood.
Identifying the substrates of these kinases should further the
understanding of their cellular roles. In the present work, the
transcription modulator, TMF, was identi¢ed as a putative
substrate of the FER tyrosine kinases. This protein was
shown to bind to the TATA element of RNA polymerase II
promoters and consequently repressed their activity by com-
peting the binding of TBP [12]. As was shown for various
transcription factors, phosphorylation of TMF by the FER
tyrosine kinases might modulate its activity. The induction of
the p94fer phosphorylation activity upon stimulation of cells
with growth factors [25] linked the functioning of p94fer to cell
growth processes. p94fer may thus modulate the suppressive
activity of TMF in somatic cell growth and di¡erentiation
processes while p51ferT may exert this function during meiosis.
TMF is thus the ¢rst mammalian suppressor of transcription
whose function might be a¡ected by its tyrosine phosphory-
lation.
How do the FER tyrosine kinases modulate the suppressive
activity of TMF?
Deletion mapping analysis indicated that the FER phos-
phorylation targets, reside within the carboxy-terminus of
TMF (Figs. 5 and 1). Computer analysis using the PROSITE
application revealed the existence of two potential tyrosine
phosphorylation sites in TMF. One site, KLEDENNRY866,
extends from Lys-858 to Tyr-866, and the other,
RDLDQRY1052, lies between Arg-1046 and Tyr-1052. These
two sites, which are highly conserved in the mouse and human
TMF proteins (Schwartz and Nir, unpublished data), lie with-
in the carboxy-terminal region of TMF (Fig. 1). The putative
Tyr-1052 phosphorylation site resides within a potential coiled
coil region which composes the carboxy-terminal end of TMF
[12]. p94fer and p51ferT could thus modulate the functioning of
TMF by a¡ecting its oligomerization either with itself or with
other cellular protein(s). This may a¡ect the DNA binding
activity or the subcellular distribution pro¢le of TMF during
cell growth and di¡erentiation processes. Interestingly, anoth-
er nuclear tyrosine kinase, c-Abl, was shown to potentiate the
activity of RNA polymerase II during S phase progression in
mammalian cells [37]. Nuclear tyrosine kinases may thus exert
at least part of their regulatory functions by modulating the
transcription machinery in mammalian cells.
TMF is a ubiquitously expressed gene. As was shown for
the human TMF gene [12], two transcripts of 4 and 4.5 kb
were found in all tissues examined (Fig. 5). These transcripts
accumulate, however, to high levels in murine testis (Fig. 5).
In situ localization revealed that, within the gonads, TMF
transcripts are preferentially expressed in meiotic cells (Fig.
6), In the testis from around mid-pachytene stage to round
spermatids, and in the ovary from secondary oocyte stage
until, at least, ovulation. Further characterization of the two
TMF transcripts should reveal whether they encode di¡erent
proteins, and whether they accumulate at di¡erent levels in
the spermatogenic and oogenic cells.
The relatively high expression levels of TMF RNA in both
spermatogenic and oogenic cells suggest a functional role of
TMF protein during meiosis. Interestingly, the testis-speci¢c
form of the FER kinases, p51ferT, is highly expressed in pa-
chytene spermatocytes [20,24] which also harbor high levels of
the TMF transcripts (Fig. 6). It is thus plausible that p51ferT
serves as a modulator of TMF phosphorylation and activity,
at de¢ned spermatogenic stages.
Further studies on the modulation of TMF activity by the
FER proteins should reveal what roles are played by nuclear
tyrosine kinases in control of nuclear suppressive activities
during the progression of the mammalian cell cycle and de-
¢ned di¡erentiation pathways.
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